Blog
RSS FeedPosted by Michael Wonder on 08 Jun 2022
PHARMAC says funding Trikafta would take 'almost all' new money
8 June 2022 - PHARMAC's chairman says funding the cystic fibrosis drug Trikafta would swallow nearly all the new money ...
Posted by Michael Wonder on 02 Jun 2022
Hope for change after PHARMAC independent review
2 June 2022 - A woman who had her bowel removed while she waited for drugs that would probably have ...
Posted by Michael Wonder on 24 May 2022
Budget 2022: PHARMAC funding boost a 'glimpse of hope' for cystic fibrosis sufferer
25 May 2022 - For the first time in his life, Troy Watson thought he was going to "lose the ...
Posted by Michael Wonder on 19 May 2022
Budget 2022: critically ill patients 'bitterly disappointed' by PHARMAC funding
19 May 2022 - Critically ill patients say they're "bitterly disappointed" by today's PHARMAC Budget announcement and were left looking ...
Posted by Michael Wonder on 19 May 2022
Budget 2022: PHARMAC boost leaves patients cold: 'it won't be enough'
19 May 2022 - PHARMAC has had its biggest ever funding boost, but some New Zealanders fear it still won’t ...
Posted by Michael Wonder on 19 May 2022
Multiple funding proposals being considered by PHARMAC
19 May 2022 - PHARMAC has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, ...
Posted by Michael Wonder on 19 May 2022
PHARMAC will use biggest budget increase ever to fund more medicines for more New Zealanders
19 May 2022 - PHARMAC welcomes the $191 million increase to its pharmaceutical budget over the next two years. ...
Posted by Michael Wonder on 18 May 2022
Budget 2022: two year old girl and mum travel to Wellington in hopes of getting funding for devastating spinal illness
19 May 2022 - Dozens of people are travelling to Wellington for the Budget to highlight concerns about sick children ...
Posted by Michael Wonder on 25 Apr 2022
Is it best to remove insurance benefits from drugs prescribed in bribery?
25 April 2022 - The Ministry of Health and Welfare’s Health Insurance Policy Review Committee is scheduled to hold a ...
Posted by Michael Wonder on 31 Mar 2022
Statement from Rare Disorders NZ re Minister Little's comments on PHARMAC funding
31 March 2022 - Rare Disorders NZ is extremely frustrated to hear the Minister of Health this week dismiss the call ...
Posted by Michael Wonder on 19 Mar 2022
Medical devices savings ‘missed’
17 March 2022 - Private health insurers say consumers will miss out on big savings on their premiums because the ...
Posted by Michael Wonder on 17 Mar 2022
‘Keytruda reimbursement provides global standard care for Korean lung cancer patients’
17 March 2022 - MSD’s Keytruda (pembrolizumab) became reimbursable for the first-line treatment of non-small-cell lung cancer in March, enabling ...
Posted by Michael Wonder on 16 Mar 2022
Consequences of lack of funding for efforts to combat COVID-19 if Congress does not act
15 March 2022 - The U.S. has made tremendous progress in our fight against COVID-19. ...
Posted by Michael Wonder on 15 Mar 2022
Better care and treatment for Australians with blood cancer
15 March 2022 - Australians with blood cancer will receive improved treatment and care through new and continued funding from the ...
Posted by Michael Wonder on 11 Mar 2022
Diabetes NZ to kick-start campaign for PHARMAC funding for glucose monitors
11 March 2022 - Diabetes NZ wants PHARMAC to fund next-generation blood sugar monitors for people with the debilitating disease. ...